logo
Select company
Select metric
-3790.25%Net Margin
VS
Market
3
Sector
11
Industry
20
History
24
$ 9.01Close
$ 8.77 - $ 25.14 52-Week Range
Ticker Information

Ticker

RNAC

Company Name

CARTESIAN THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CARTESIAN THERAPEUTICS INC - Net Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RNAC - Net % Historical data
DateNet Income Common StockNet MarginRevenues
6/30/2025$ -38.89M-3790.25%$ 1.03M
3/31/2025$ -42.52M-124.42%$ 34.17M
12/31/2024$ -77.42M-198.97%$ 38.91M
9/30/2024$ -249.04M-519.5%$ 47.94M
6/30/2024$ -233.86M-432.25%$ 54.1M
3/31/2024$ -254.87M-983.83%$ 25.91M
12/31/2023$ -219.71M-844.91%$ 26M
9/30/2023$ -36.16M-104.71%$ 34.53M
6/30/2023$ -35.05M-71.98%$ 48.69M
3/31/2023$ -15.06M-18.21%$ 82.72M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CARTESIAN THERAPEUTICS INC's latest trailing twelve months (TTM) Net % stands at -604.58%.
  • Over the past 5 years, CARTESIAN THERAPEUTICS INC's average Net % has been -423.25%.
  • The median Net % for CARTESIAN THERAPEUTICS INC during this period was -114.56%
  • CARTESIAN THERAPEUTICS INC reached its highest Net % over the past 5 years at 33.67%.
  • The lowest Net % recorded by CARTESIAN THERAPEUTICS INC in the same timeframe -3790.25%

CARTESIAN THERAPEUTICS INC's Net % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Net % Benchmarks
CompanyNet %
HUMA : HUMACYTE INC -7171.27%NWBO : NORTHWEST BIOTHERAPEUTICS INC -7636.93%MREO : MEREO BIOPHARMA GROUP PLC -9910%INBX : INHIBRX BIOSCIENCES INC -11692.43%CRDF : CARDIFF ONCOLOGY INC -9348.53%BTAI : BIOXCEL THERAPEUTICS INC -5869.82%CATX : PERSPECTIVE THERAPEUTICS INC -7688.5%ADVM : ADVERUM BIOTECHNOLOGIES INC -18387.4%SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC -1355.62%LSTA : LISATA THERAPEUTICS INC -1768.5%

Definition of Net Margin

[Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
Net Inc. Cmn. / Revenues
(=) Net %
Net % for CARTESIAN THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -68.32M ] / Revenues [ $ 11.3M ]
(=) Net % [ -604.58% ]

RNAC - Net Margin, Last 5 years

-3790.25%

Minimum

Jun 30, 2025

33.67%

Maximum

Sep 30, 2022

-423.25%

Average

-114.56%

Median

Net % Benchmark Analysis

The chart above depicts the distribution of Net % for companies in the Total Stock Market. The average Net % of the companies is 4.77% with a standard deviation of 19.84%.
The following table provides additional summary stats:
Net % in the Market:
filtered constituents3.2K
min-64.23%
max69.74%
average4.77%
median5.24%
std19.84%